170 related articles for article (PubMed ID: 34811582)
1. No association between acid suppressant use and risk of dementia: an updated meta-analysis.
Wang H; Tian L; Yan X
Eur J Clin Pharmacol; 2022 Mar; 78(3):375-382. PubMed ID: 34811582
[TBL] [Abstract][Full Text] [Related]
2. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
[TBL] [Abstract][Full Text] [Related]
3. Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis.
Kim HB; Kim JH; Wolf BJ
Eur J Clin Pharmacol; 2022 Mar; 78(3):383-391. PubMed ID: 34817624
[TBL] [Abstract][Full Text] [Related]
4. A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users.
Hwang IC; Chang J; Park SM
Am J Geriatr Psychiatry; 2018 Nov; 26(11):1175-1183. PubMed ID: 30072307
[TBL] [Abstract][Full Text] [Related]
5. Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma.
Van De Sijpe G; Beuselinck B; Van Nieuwenhuyse T; Poncelet R; Bechter O; Albersen M; Roussel E; Baldewijns M; Tack J; Spriet I
Eur J Clin Pharmacol; 2020 Sep; 76(9):1273-1280. PubMed ID: 32474662
[TBL] [Abstract][Full Text] [Related]
6. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
[TBL] [Abstract][Full Text] [Related]
7. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis.
Laoveeravat P; Thavaraputta S; Vutthikraivit W; Suchartlikitwong S; Mingbunjerdsuk T; Motes A; Nugent K; Rakvit A; Islam E; Islam S
QJM; 2020 Feb; 113(2):100-107. PubMed ID: 31503318
[TBL] [Abstract][Full Text] [Related]
9. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
10. Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis.
Ahn N; Nolde M; Krause E; Güntner F; Günter A; Tauscher M; Gerlach R; Meisinger C; Linseisen J; Baumeister SE; Rückert-Eheberg IM
Br J Clin Pharmacol; 2023 Feb; 89(2):602-616. PubMed ID: 36331350
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies.
Desai M; Nutalapati V; Srinivasan S; Fathallah J; Dasari C; Chandrasekhar VT; Mohammad B; Kohli D; Vaezi M; Katz PO; Sharma P
Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32476013
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule.
Puig I; Calzado S; Suárez D; Sánchez-Delgado J; López S; Calvet X
Pharmacol Res; 2012 Apr; 65(4):480-90. PubMed ID: 22289674
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
Kweon T; Kim Y; Lee KJ; Seo WW; Seo SI; Shin WG; Shin DH
Sci Rep; 2023 Dec; 13(1):21169. PubMed ID: 38036592
[TBL] [Abstract][Full Text] [Related]
14. Association Between Proton Pump Inhibitor Use and Cognitive Function in Women.
Lochhead P; Hagan K; Joshi AD; Khalili H; Nguyen LH; Grodstein F; Chan AT
Gastroenterology; 2017 Oct; 153(4):971-979.e4. PubMed ID: 28728964
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy.
Li CM; Zhernakova A; Engstrand L; Wijmenga C; Brusselaers N
Aliment Pharmacol Ther; 2020 Feb; 51(4):410-420. PubMed ID: 31909512
[TBL] [Abstract][Full Text] [Related]
16. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
[TBL] [Abstract][Full Text] [Related]
17. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
[TBL] [Abstract][Full Text] [Related]
18. Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies.
Babic A; Zhang X; Morales-Oyarvide V; Yuan C; Khalaf N; Khalili H; Lochhead P; Chan AT; Ogino S; Wolpin BM; Wu K; Fuchs CS; Giovannucci EL; Stampfer MJ; Ng K
Br J Cancer; 2020 Sep; 123(5):844-851. PubMed ID: 32541871
[TBL] [Abstract][Full Text] [Related]
19. Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies.
Yang J; Zhou TJ; Yang J; Bao DN
Eur J Clin Pharmacol; 2022 Mar; 78(3):365-373. PubMed ID: 34705066
[TBL] [Abstract][Full Text] [Related]
20. Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
Lyu B; Hansen KE; Jorgenson MR; Astor BC
Am J Nephrol; 2020; 51(6):433-441. PubMed ID: 32485707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]